Bio

Timothy Ehrlich focuses on the representation of start-up, emerging growth and public life science companies in the biotechnology, pharmaceutical, medical device, diagnostics and healthcare IT industries. His practice spans the entire corporate lifecycle, from formation through liquidity and he regularly serves as principal outside or general counsel to his clients. Tim is broadly experienced in business formation and entity selection, deal structuring, equity and debt financing transactions, general corporate and governance matters, as well as M&A events and public offerings. In addition to his company client counsel, Tim represents a number of prominent venture capital funds and institutional investors in their financing activities. Tim also has particular expertise in structuring and negotiating strategic alliances, including “bet-the-company” intellectual property collaborations, and joint ventures and providing strategic counseling and advice regarding intellectual property protection and commercialization. Tim has spoken in a number of forums and authored articles on corporate structuring and capital raising, technology licensing and intellectual property matters and related business strategies that affect strategic alliances. He is also a co-author of the treatise “Corporate Partnering, Structuring and Negotiating Domestic and International Strategic Alliance” (Aspen Publishers). He has participated as a presenter and moderator at numerous conferences and has taught classes on both the East and West Coasts relating to entrepreneurship, venture capital and intellectual property matters, including at Berkeley, Boston University, Harvard, Princeton and Stanford. Prior to joining the firm Tim worked in the Silicon Valley office of Latham & Watkins LLP where he had a similar type of practice representing West Coast-based companies. Prior to entering into private practice, Tim served as a law clerk to the Honorable Thomas Penfield Jackson of the United States District Court in Washington, D.C. where he was primarily responsible for the case of US v. Microsoft. Tim currently serves as an advisor to the Harvard Law Entrepreneurship Program at Harvard Law School and the Harvard University iLab. He is a member of the State Bars of California and Massachusetts. Tim received his J.D., cum laude, from Harvard Law School, where he was an editor of the Harvard Journal of Law and Technology. He received an A.B., summa cum laude, from Princeton University where he was elected to Phi Beta Kappa, selected as a national finalist for the Rhodes Scholarship, and was a four year member of the 1993 national championship varsity squash team. Tim has been recognized by a number of industry groups and publications as a national leader for his corporate and transactional work including, since its inception in 2012, by LMG Life Sciences as a “Life Sciences Star.” He has also been nominated in 2020 and 2021 for “VC Lawyer of the Year” by LMG Life Sciences.